Literature DB >> 2225312

Comparison of acute effects of anthracyclines on cardiac electrophysiological parameters of isolated guinea-pig hearts.

G Stark1, U Stark, H Samonigg, K Kasparek, A Lueger, S Nagl, H Bertuch, E Pilger, H A Tritthart.   

Abstract

This study was performed to evaluate the acute effects of two anthracycline derivatives, doxorubicin and 4'O-tetrahydropyranyl-doxorubicin [(THP)-doxorubicin], on the conduction intervals, heart rate and refractoriness of isolated spontaneously beating guinea-pig hearts using a high-resolution ECG recording technique (SST-ECG). Doxorubicin as well as (THP)-doxorubicin were added to the perfusate in increasing concentrations of 0.1, 1 and 10 microM. Doxorubicin did not significantly alter the heart rate or conduction intervals. Only the rate-dependent QT interval was significantly shortened under the influence of 10 microM doxorubicin. In contrast, 10 microM (THP)-doxorubicin led to a significant reduction in the heart rate (-13% +/- 3%; P less than 0.01, n = 7) and to a prolongation of atrioventricular conduction time (24% +/- 10%; P less than 0.05, n = 7). The rate-dependent repolarization period (QT interval) was only insignificantly shortened in the presence of 10 microM (THP)-doxorubicin. The maximal following frequencies of each part of the conduction system were not changed by 10 microM doxorubicin. In the presence of (THP)-doxorubicin, the maximal following frequency of the ventricular myocardium was increased by as much as 36% +/- 8% (P less than 0.01, n = 7), indicating a shortening of the effective refractory period of the ventricular myocardium (V-ERP). These results show that the activation of (THP)-doxorubicin resembles the effects of Ca-antagonistic compounds on the heart (i.e. decrease in the spontaneous sinus rate and prolongation of the AV-nodal conduction interval). Changes in the QT interval exerted by doxorubicin and the shortening of the ventricular effective refractory period by (THP)-doxorubicin may indicate an alteration of the K(+)-conductance of the membrane. As the acute electrophysiological effects of doxorubicin and (THP)-doxorubicin are modest and occur only at excessive concentrations (10 microM), a direct influence on the generation of arrhythmias in healthy hearts is unlikely.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2225312     DOI: 10.1007/bf02994091

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  22 in total

1.  Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.

Authors:  F M Torti; M M Bristow; B L Lum; S K Carter; A E Howes; D A Aston; B W Brown; J F Hannigan; F J Meyers; E P Mitchell
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

2.  [Effect of (2"R)-4'-O-tetrahydropyranyladriamycin, a new antitumor antibiotic, on the cardiac function of hamsters].

Authors:  H Tone; S Hirano; M Shirai; H Kumagai; Y Okajima; T Wakabayashi
Journal:  Jpn J Antibiot       Date:  1986-02

3.  Comparative trial of adriamycin and 5-fluorouracil in advanced prostatic cancer--progress report.

Authors:  W D DeWys; M Bauer; J Colsky; R A Cooper; R Creech; P P Carbone
Journal:  Cancer Treat Rep       Date:  1977 Mar-Apr

4.  Sudden death during doxorubicin administration.

Authors:  J E Wortman; V S Lucas; E Schuster; D Thiele; G L Logue
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

5.  Weekly doxorubicin in endocrine-refractory carcinoma of the prostate.

Authors:  F M Torti; D Aston; B L Lum; M Kohler; R Williams; J T Spaulding; L Shortliffe; F S Freiha
Journal:  J Clin Oncol       Date:  1983-08       Impact factor: 44.544

6.  Aclarubicin-associated QTc prolongation and ventricular fibrillation.

Authors:  N Iwata; M Karasawa; M Omine; T Maekawa; T Suzuki; Y Kawai
Journal:  Cancer Treat Rep       Date:  1984-03

7.  [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].

Authors:  O Nakajima; Y Imamura; A Matsumoto; Y Koyama; T Shomura; K Kawamura; S Murata
Journal:  Gan To Kagaku Ryoho       Date:  1986-02

8.  Anthracycline cardiomyopathy monitored by morphologic changes.

Authors:  M E Billingham; J W Mason; M R Bristow; J R Daniels
Journal:  Cancer Treat Rep       Date:  1978-06

9.  Modulation of cardiac impulse generation and conduction by nifedipine and verapamil analyzed by a refined surface ECG technique in Langendorff perfused guinea pig hearts.

Authors:  G Stark; U Stark; H A Tritthart
Journal:  Basic Res Cardiol       Date:  1988 Mar-Apr       Impact factor: 17.165

10.  [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG].

Authors:  K Okuma; I Furuta; K Ota
Journal:  Gan To Kagaku Ryoho       Date:  1984-04
View more
  1 in total

1.  Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks).

Authors:  Joffrey Ducroq; H Moha ou Maati; S Guilbot; S Dilly; E Laemmel; C Pons-Himbert; J F Faivre; P Bois; O Stücker; M Le Grand
Journal:  Br J Pharmacol       Date:  2009-08-24       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.